Botulinum toxin augmented surgery vs conventional surgery in the management of large angle infantile esotropia

Botulinum toxin augmented surgery versus conventional surgery in the management of large angle infantile esotropia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201709002522352

Enrollment

Registered

2017-08-17

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases Surgery infantile esotropia

Interventions

botulinum toxin augmented bimedial recession

conventional surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Large angle infantile esotropia (>60 prism diopters)

Exclusion criteria

Exclusion criteria: Other neurologic, ocular, or developmental disorders Oblique muscle dysfunction Vertical deviation Significant A or V patterns Paralytic or restrictive forms of strabismus History of eye surgery (strabismus or otherwise)

Design outcomes

Primary

Measure	Time frame
success rate	—

Secondary

Measure	Time frame
degree of ocular alignment;incidence of complications	—

Countries

Egypt

Contacts

Public ContactSara Alattar

assiut university

alattarsara@yahoo.com+201004450144

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026